Medisca Dye-Free Oral Bases

Download in electronic PDF format for $25



Search the Complete Journal Archives

Ronidazole in the Treatment of Trichomonad Infections in Cats

Author(s):  Davidson Gigi S

Issue:  Nov/Dec 2006 - Veterinary Compounding
View All Articles in Issue

Abstract:  Tritrichomonas foetus, a microscopic single-celled flagellated protozoan parasite, traditionally identified as a cause of reproductive disease in cattle, has been demonstrated as an important cause of diarrhea in cats. Until recently, an effective antimicrobial treatment for feline Tritrichomonas foetus had not been identified. Since recommended dosages of antimicrobial drugs have failed in cats infected with Tritrichomonas foetus and in vitro studies have revealed multiple drug resistance, investigations continue in the effort to find an effective treatment. One particular study by Dr. Jody Gookin noted no clinicopathological abnormalities or adverse effects with the use of ronidazole, and the research concluded that ronidazole administered at 30 to 50 mg/kg orally twice daily for 2 weeks was capable of resolving diarrhea and eradicating infections of Tritrichomonas foetus in cats. Clinical use of ronidazole has revealed a reversible, possibly dose-related, neurotoxicity. Cats receiving ronidazole should be

Related Keywords: Gigi S Davison, BS, RPh, FSVHP, DICVP, cats, Tritrichomonas foetus, trichomonad infection, protozoa, parasites, parasitic infection, ronidazole, antibiotics, antimicrobial agent, antiparasitic agent, diarrhea, adverse effects, side effects, drug safety, neurotoxicity, nystagmus, ataxia, behavioral disorders, dosage forms, dosing, veterinary

Related Categories: VETERINARY, ADVERSE DRUG EVENTS, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE, NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Ronidazole in the Treatment of Trichomonad Infections in Cats Davidson Gigi S Nov/Dec 2006 434-435 Buy
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr Jul/Aug 2001 310 Buy
Compounding for Treatment of Equine Infectious Diseases: An Overview Bramwell Bethany L Nov/Dec 2011 450-457 Buy
Compounding for the Effects of Weapons of Mass Destruction Sammarco Domenic A Jan/Feb 2003 10 View Sample
Aztreonam Injection Allen Loyd V Jr Jan/Feb 2014 60 Buy
Basics of Compounding for Terrorist Attacks, Part 2 Allen Loyd V Jr Mar/Apr 2003 129 View Sample
Compounding for Feline Herpetic Keratitis Davidson Gigi S Nov/Dec 2006 411-414 Buy
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Ploesser Jennifer, Weinstock Leonard B, Thomas Erin Mar/Apr 2010 171-173 Buy
Topical Cidofovir for Treatment of Resistant Viral Infections McElhiney Linda F Sep/Oct 2006 324-328 Buy
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Klemmer Anja, Krämer Irene, Kamin Wolfgang May/Jun 2013 254-261 Buy